Online Purchasing Account You are logged on as Guest. Login Register a New Account Shopping cart (Empty)

Sp-cAMPS

PKA activator



BML-CN136-0001	1 mg	85.00 USD
Do you need bulk/larger quantities?

Replaces Prod. #: ALX-480-013

Sp-cAMPS is a potent and specific activator of cAMP-dependent protein kinases. Its cell permeability and complete resistance to cyclic nucleotide phosphodiesterases make it a unique tool for studying cAMP-dependent signaling. Has a considerably higher resistance against cyclic nucleotide-dependent phosphodiesterases as compared to dibutyryl-cAMP or 8-Br-cAMP. Concentration for half-maximal activation is 1.8µM. The product is not sterile. No metabolic side effects.

Product Details

Formula:	C₁₀H₁₁N₅O₅PS . C₆H₁₆N

MW:	446.5

CAS:	93602-66-5

Purity:	≥98% (HPLC)

Identity:	Determined by UV-VIS and ESI-MS.

Appearance:	Lyophilized solid.

Solubility:	Soluble in water (25mg/ml), DMSO, dimethyl formamide or methanol

Shipping:	Ambient Temperature

Long Term Storage:	-20°C

Use/Stability:	Store, as supplied, at -20°C for up to one year. Store solutions at -20°C for up to 3 months.

Regulatory Status:	RUO - Research Use Only

Please mouse over

Product Literature References

Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction: W. Van der Kloot & D.D. Branisteanu; Pflugers Arch. 420, 336 (1992), Abstract;

Intracellular cyclic AMP not calcium, determines the direction of vesicle movement in melanophores: direct measurement by fluorescence ratio imaging: P.J. Sammak et al.; J. Cell. Biol. 117, 57 (1992), Abstract;

Second messenger signaling in the regulation of cytosolic pH and DNA synthesis by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: role of Na+/H+ exchange: T. Sugimoto et al.; J. Cell. Physiol. 152, 28 (1992), Abstract;

The activation of cAMP-dependent protein kinase is directly linked to the stimulation of bone resorption by parathyroid hormone: H. Kaji et al.; Biochem. Biophys. Res. Commun. 182, 1356 (1992), Abstract;

Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3’,5’-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells: M. Sandberg et al.; Biochem. J. 279 , 521 (1991), Abstract;

Cyclic AMP antagonist Rp-cAMPS inhibits amylase exocytosis from saponin-permeabilized parotid acini: T. Takuma & T. Ichida ; J. Biochem. 110, 292 (1991), Abstract;

Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3’,5’-cyclic phosphorothioates: W.R.G. Dostmann et al.; J. Biol. Chem. 265, 10484 (1990), Abstract;

A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3’,5’-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase: J.D. Rothermel et al.; Biochem. J. 251, 757 (1988), Abstract;

Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis: T. Braumann et al.; Biochim. Biophys. Acta. 871, 199 (1986), Abstract;